Teva has refuted accusations of “meddling” with Mylan’s business in the latest chapter of what one analyst says is a far from friendly, if not hostile takeover attempt.
Botox maker Allergan announced sales and earnings per share growth above the high end of its expectations, but it will cut 1,500 jobs, or about 13% of its workforce as it continues to avoid a $54bn hostile takeover bid from Valeant Pharmaceuticals.
Pfizer will keep a “substantial” level of manufacturing in the UK if it takes over AstraZeneca, said the CEO in a letter to the country’s Prime Minister.
Rumours suggest that Genzyme would consider accepting lower value takeover bids that take into account future performance of its cancer drug Campath in MS indications.
Roche has stepped up its pursuit of Genentech, launching a hostile bid of $42bn after growing frustrated with the lack of progress over the past six months.
The Tel-Aviv District Court has found in favour of Sun Pharmaceuticals in its long running struggle to acquire Israeli drug and pharmaceutical ingredient maker Taro Pharmaceutical Industries.
The latest twist in Roche's long-running bid to acquire diagnostics
expert Ventana has seen the pharma giant announce it intends to
elect directors to Ventana's board at its next AGM (annual general
meeting).
Roche's latest takeover bid extension has been brushed off by
histopathology diagnostics expert Ventana as it believes 'it is
worth significantly more' than the current $3bn (€2.1bn) offer.
After months of speculation, chemical giants BASF have put in a
$4.9 billion (€4.1 billion) offer for the Engelhard Corporation,
which if successful, would become BASF's largest acquisition to
date, surpassing Dow Chemical as...
Switzerland's Novartis has confirmed that it is in discussions with
Aventis which could lead to a counter-offer to fend off the hostile
takeover bid from France's Sanofi-Synthelabo.
A rheumatoid arthritis drug developed by Franco-German company
Aventis has been linked to the deaths of five patients in Japan,
prompting the company to warn against prescribing the drug to
people with respiratory problems.
